Since chronic high levels of blood FGF21 are a risk factor for several metabolic diseases [15, 21, 25], it is necessary to evaluate whether insulin dose simply affects FGF21 secretion and/or FGF21-related metabolic diseases. Here, INS is linked to metabolic disease.